Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.

Kazuhiro NishikawaHisato KawakamiToshio ShimokawaKazumasa FujitaniShigeyuki TamuraShunji EndoMichiya KobayashiJunji KawadaYukinori KurokawaAkira TsuburayaTakaki YoshikawaJunichi SakamotoTaroh Satohnull null

Published in: International journal of clinical oncology (2023)

The HERBIS-2, HERBIS-4A, and XParTS II trials were registered with UMIN-CTR as UMIN000006105, UMIN000006755, and UMIN000006045, respectively.

Keyphrases

systematic review
neoadjuvant chemotherapy
meta analyses
locally advanced
phase ii study
squamous cell carcinoma
case control
lymph node
metastatic colorectal cancer